Page last updated: 2024-11-06

arsenic trisulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID71586773
MeSH IDM0133048

Synonyms (49)

Synonym
arsenic sulfide yellow
arsenic red
einecs 215-117-4
hsdb 428
diarsenic trisulphide
arsenic sulfide (as0.4s0.6)
ci 77086
yellow arsenic sulfide
shio
ai3-01006
arsenic sesquisulphide
arsenic tersulphide
arsenic sulfide (as2s3), (yellow)
sekio
arsenic sesquisulfide
king's gold
c.i. 77086
arsenic tersulfide
arsenous sulfide
arsenic sulphide
na1557
arsenic yellow
diarsenic trisulfide
arsenic trisulfide
arsenious sulfide
arsenic trisulphide
arsenious sulphide
arsenic sulphides, natural
arsenic trisulfide [na1557] [poison]
arsenic sulfide [na1557] [poison]
unii-44sij800ox
44sij800ox ,
arsenicum sulphuratum flavum
arsenic trisulfide [who-dd]
arsenic trisulfide [mi]
arsenicum sulphuratum flavum [hpus]
arsenic trisulfide [hsdb]
arsenic sulphide (as2s3)
arsenic(iii) sulphide
yellow arsenic sulphide
DTXSID50274153 ,
Q425065
arsenous sulphide
arsenic trisulfide (as2s3)
arsenic sulfide (ass1.5)
dtxcid80196556
natural orpiment
arsenic sesquisulfide (as2s3)
pesticide code: 006901

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"To study if the effect of arsenic sulfide combined with IFN-alpha can be increased on K562 cells."( [The effect of arsenic sulfide combined with IFN-alpha on K562 cells].
Li, J; Liu, SX; Zhang, M, 2009
)
0.35
" We investigated if arsenic sulfide (As4S4) in combination with other distinct agents could enhance its cytotoxic activity."( Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X, 2015
)
0.42
"We used gastric and colon cancer cell lines to study the synergistic effect of As4S4 in combination with BRD4 inhibitor JQ1, or with chemotherapy drug cisplatin and irinotecan or with COX2 inhibitor celecoxib."( Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X, 2015
)
0.42
"We found that when As4S4 was combined with JQ1, cisplatin, irinotecan or celecoxib, its cytotoxic activity was dramatically enhanced in both gastric and colon cancer cell lines."( Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X, 2015
)
0.42
"As4S4 in combination with JQ1, cisplatin, irinotecan or celecoxib showed enhanced cytotoxic effect on gastric and colon cancer cells, indicating the potential application of these novel drug combinations as part of treatment strategy that warrants further investigation."( Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" Orpiment and realgar are less soluble and poorly absorbed from the gastrointestinal tract, whereas the bioavailability of arsenic trioxide is similar to inorganic arsenic salts such as sodium arsenite."( Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite.
Goyer, RA; Liu, J; Lu, Y; Waalkes, MP; Wu, Q, 2008
)
0.35
"Traditional Chinese medicines (TCM) are increasingly being used as alternative medicines in many countries, and this has caused concern because of adverse health effects from toxic metal bioavailability such as mercury (Hg) and arsenic (As)."( Bioavailability study of arsenic and mercury in traditional Chinese medicines (TCM) using an animal model after a single dose exposure.
Ng, J; Noller, B; Sadler, R; Seawright, A; Tinggi, U, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" High dosage of arsenic sulfide can slightly induce differentiation of HL-60 cells."( [Changes of telomerase activity and hTERT mRNA expression in the process of apoptosis of HL-60 cells induced by arsenic sulfide].
Li, J; Liu, SX, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (97)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (4.12)18.7374
1990's3 (3.09)18.2507
2000's28 (28.87)29.6817
2010's53 (54.64)24.3611
2020's9 (9.28)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.06%)6.00%
Case Studies1 (1.02%)4.05%
Observational0 (0.00%)0.25%
Other94 (95.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]